Literature DB >> 9405094

TAL1/SCL is expressed in endothelial progenitor cells/angioblasts and defines a dorsal-to-ventral gradient of vasculogenesis.

C J Drake1, S J Brandt, T C Trusk, C D Little.   

Abstract

In this study we establish that TAL1/SCL, a member of the helix-loop-helix family of transcription factors, and an important regulator of the hematopoietic lineage in mice, is expressed in the endothelial lineage of avians. The earliest events of vascular development were examined using antibodies to TAL1/SCL, and the QH1 antibody, an established marker of quail endothelial cells. Analyses using double immunofluorescence confocal microscopy show that: (i) TAL1/SCL is expressed by both quail and chicken endothelial cells; (ii) TAL1/SCL expression precedes that of the QH1 epitope; and (iii) TAL1/SCL, but not QH1, expression defines a subpopulation of primordial cells within the splanchnic mesoderm. Collectively these data suggest that TAL1/SCL-positive/QH1-negative cells are angioblasts. Further, using TAL1/SCL expression as a marker of the endothelial lineage, we demonstrate that in addition to the previously described cranial-to-caudal gradient, there is a dorsal-to-ventral progression of vasculogenesis. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9405094     DOI: 10.1006/dbio.1997.8751

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  39 in total

1.  Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo.

Authors:  M F de Bruijn; N A Speck; M C Peeters; E Dzierzak
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

Review 2.  Cellular precursors of the coronary arteries.

Authors:  Ramón Muñoz-Chápuli; Mauricio González-Iriarte; Rita Carmona; Gerardo Atencia; David Macías; José María Pérez-Pomares
Journal:  Tex Heart Inst J       Date:  2002

3.  Rho activity critically and selectively regulates endothelial cell organization during angiogenesis.

Authors:  Mien V Hoang; Mary C Whelan; Donald R Senger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

4.  Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration.

Authors:  Susan M Majka; Kathyjo A Jackson; Kirsten A Kienstra; Mark W Majesky; Margaret A Goodell; Karen K Hirschi
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

5.  Vasculogenesis and angiogenesis: molecular and cellular controls. Part 1: growth factors.

Authors:  N Kubis; B I Levy
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

6.  cis-Regulatory remodeling of the SCL locus during vertebrate evolution.

Authors:  Berthold Göttgens; Rita Ferreira; Maria-José Sanchez; Shoko Ishibashi; Juan Li; Dominik Spensberger; Pascal Lefevre; Katrin Ottersbach; Michael Chapman; Sarah Kinston; Kathy Knezevic; Maarten Hoogenkamp; George A Follows; Constanze Bonifer; Enrique Amaya; Anthony R Green
Journal:  Mol Cell Biol       Date:  2010-10-18       Impact factor: 4.272

7.  Vascular sprout formation entails tissue deformations and VE-cadherin-dependent cell-autonomous motility.

Authors:  Erica D Perryn; András Czirók; Charles D Little
Journal:  Dev Biol       Date:  2007-11-04       Impact factor: 3.582

Review 8.  Multicellular sprouting during vasculogenesis.

Authors:  Andras Czirok; Evan A Zamir; Andras Szabo; Charles D Little
Journal:  Curr Top Dev Biol       Date:  2008       Impact factor: 4.897

Review 9.  Endothelium as master regulator of organ development and growth.

Authors:  Daniela Tirziu; Michael Simons
Journal:  Vascul Pharmacol       Date:  2008-09-05       Impact factor: 5.773

10.  Human disease modeling reveals integrated transcriptional and epigenetic mechanisms of NOTCH1 haploinsufficiency.

Authors:  Christina V Theodoris; Molong Li; Mark P White; Lei Liu; Daniel He; Katherine S Pollard; Benoit G Bruneau; Deepak Srivastava
Journal:  Cell       Date:  2015-03-12       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.